ArticleBiomedical optics express2022
Inter-day repeatability assessment of human retinal blood flow using clinical laser speckle contrast imaging.
Article in Biomedical optics express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 3 citations in OpenAlex.
- Intraday and Interday Repeatability of Laser Speckle Contrast Imaging for Ocular Blood Flow Measurement in Healthy Subjects.Translational vision science & technology · 2026Article
- Lightweight denoising speckle contrast image GAN for real-time denoising of laser speckle imaging of blood flow.Biomedical optics express · 2025Article
- Factors Associated With Ocular Perfusion Measurements as Obtained With Laser Speckle Contrast Imaging.Translational vision science & technology · 2024Article
- Adaptive window space direction laser speckle contrast imaging to improve vascular visualization.Biomedical optics express · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laser speckle contrast imaging (LSCI) can generate retinal blood flow maps inexpensively and non-invasively. These flow maps can be used to identify various eye disorders associated with reduced blood flow. Despite early success, one of the major obstacles to clinical adoption of LSCI is poor repeatability of the modality. Here, we propose an LSCI registration pipeline that registers contrast maps to correct for rigid movements. Post-registration, intra(same)-day and inter(next)-day repeatability are studied using various quantitative metrics. We have studied LSCI repeatability intra-day by using the coefficient of variation. Using the processing pipelines and custom hardware developed, similar repeatability was observed when compared to previously reported values in the literature. Inter-day repeatability analysis indicates no statistical evidence (p = 0.09) of a difference between flow measurements performed on two independent days. Further improvements to hardware, environmental controls, and participant control must be made to provide higher confidence in the repeatability of blood flow. However, this is the first time that repeatability across two different days (inter-day) using multiple exposure speckle imaging (MESI) has been analyzed and reported.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.